Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for ICON PLC (ICLR : NSDQ)
 
 • Company Description   
ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide.

Number of Employees: 41,900

 
 • Price / Volume Information   
Yesterday's Closing Price: $114.19 Daily Weekly Monthly
20 Day Moving Average: 982,030 shares
Shares Outstanding: 80.76 (millions)
Market Capitalization: $9,221.63 (millions)
Beta: 1.28
52 Week High: $211.00
52 Week Low: $66.57
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 3.25% 7.14%
12 Week -39.33% -36.21%
Year To Date -37.33% -34.83%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
SOUTH COUNTY BUSINESS PARK LEOPARDSTOWN
-
DUBLIN 18,L2 00000
IRL
ph: 353-1291-2000
fax: 353-1247-6260
None http://www.iconplc.com
 
 • General Corporate Information   
Officers
Steve Cutler - Chief Executive Officer and Director
Ciaran Murray - Chair and Director
Barry Balfe - Chief Operating Officer
Nigel Clerkin - Chief Financial Officer
Ronan Murphy - Lead Independent Director

Peer Information
ICON PLC (CHCR)
ICON PLC (ESRX)
ICON PLC (MYDP)
ICON PLC (COR)
ICON PLC (GBCS)
ICON PLC (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: G4705A100
SIC: 8731
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/25
Next Expected EPS Date: 04/29/26
Share - Related Items
Shares Outstanding: 80.76
Most Recent Split Date: 8.00 (2.00:1)
Beta: 1.28
Market Capitalization: $9,221.63 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $3.07 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $11.91 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 7.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 3.32% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 04/29/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 9.59
Trailing 12 Months: 9.15
PEG Ratio: 2.89
Price Ratios
Price/Book: 0.99
Price/Cash Flow: 5.70
Price / Sales: 1.14
EPS Growth
vs. Year Ago Period: -12.11%
vs. Previous Quarter: -10.44%
Sales Growth
vs. Year Ago Period: 0.63%
vs. Previous Quarter: 1.26%
ROE
03/31/26 - -
12/31/25 - -
09/30/25 - 10.58
ROA
03/31/26 - -
12/31/25 - -
09/30/25 - 6.01
Current Ratio
03/31/26 - -
12/31/25 - -
09/30/25 - 1.06
Quick Ratio
03/31/26 - -
12/31/25 - -
09/30/25 - 1.06
Operating Margin
03/31/26 - -
12/31/25 - -
09/30/25 - 12.38
Net Margin
03/31/26 - -
12/31/25 - -
09/30/25 - 7.40
Pre-Tax Margin
03/31/26 - -
12/31/25 - -
09/30/25 - 7.67
Book Value
03/31/26 - -
12/31/25 - -
09/30/25 - 115.59
Inventory Turnover
03/31/26 - -
12/31/25 - -
09/30/25 - -
Debt-to-Equity
03/31/26 - -
12/31/25 - -
09/30/25 - 0.31
Debt-to-Capital
03/31/26 - -
12/31/25 - -
09/30/25 - 23.57
 

Powered by Zacks Investment Research ©